|
1）Tsukamoto Y, Okabayashi T, Hanazaki K. Progressive artificial endocrine pancreas: the era of novel perioperative blood glucose control for surgery. Surg Today 2011; 41: 1344-51
|
|
|
|
2）Bergenstal RM, Klonoff DC, Garg SK, et al. Threshold-based insulin-pump interruption for reduction of hypoglycemia. N Engl J Med. 2013; 369: 224-32
|
|
|
|
|
|
3）Russell SJ, El-Khatib FH, Sinha M, et al. Outpatient glycemic control with a bionic pancreas in type 1 diabetes. N Engl J Med. 2014; 371: 313-25
|
|
|
|
|
|
4）Phillip M, Battelio T, Atlas E, et al. Nocturnal glucose control with an artificial pancreas at a diabetes camp. N Engl J Med. 2013; 368: 824-33
|
|
|
|
|
|
5）花﨑和弘，小川道雄．人工膵臓を用いた外科周術期血糖管理．In: 花﨑和弘，編．臨床に役立つ最新血糖管理マニュアル．東京: 医学図書出版; 2012. p. 163-9
|
|
|
|
|
|
6）Hanazaki K, Kitagawa H, Yatabe T, et al. Perioperative intensive insulin therapy using an artificial endocrine pancreas with closed-loop glycemic control system: the effect of no hypoglycemia. Am J Surg. 2014; 207: 935-41
|
|
|
|
|
|
7）花﨑和弘，宗景匡哉，北川博之，他．人工臓器－最近の進歩: 新型人工膵臓の開発研究および臨床応用を中心に．人工臓器．2013; 42: 195-7
|
|
|
|
|